Stockreport

Artelo Biosciences Reports First Quarter Fiscal Year 2022 Financial Results and Provides Business Update [MarketWatch]

Artelo Biosciences, Inc.  (ARTL) 
US:NASDAQ Investor Relations: artelobio.com/investors
PDF SOLANA BEACH, Calif., Jan 12, 2022 (GLOBE NEWSWIRE via COMTEX) -- Complete Enrollment of Phase 1 CAReS Trial Anticipated by End of First Quarter of Calendar Year 2022 [Read more]